Overview
Neuroendocrine tumors (NETs) are rare tumors that arise from neuroendocrine cells, which are found throughout the body, including the pancreas. They can be functional (hormone-secreting) or non-functional.
Types of Pancreatic NETs
- Insulinomas: Secrete insulin, causing hypoglycemia.
- Gastrinomas: Secrete gastrin, leading to Zollinger-Ellison syndrome.
- Glucagonomas: Secrete glucagon, causing hyperglycemia and skin rash.
- VIPomas: Secrete vasoactive intestinal peptide, causing severe diarrhea.
- Non-functional NETs: Do not secrete hormones; may present as a mass or with symptoms due to local effects.
Symptoms
Symptoms vary based on the type of NET:
- Hypoglycemia (from insulinomas)
- Peptic ulcers (from gastrinomas)
- Diarrhea (from VIPomas)
- Weight loss
- Abdominal pain or mass
Diagnosis
Diagnosis typically involves:
- Imaging studies (CT scan, MRI, or PET scan) to locate tumors.
- Blood tests to measure hormone levels.
- Endoscopic ultrasound for biopsy or further evaluation.
Treatment
Treatment options depend on the tumor type and stage:
- Surgical resection for localized tumors.
- Medications (e.g., somatostatin analogs) for symptom control.
- Chemotherapy or targeted therapies for advanced disease.
- Peptide receptor radionuclide therapy (PRRT) for certain cases.